For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| General and administrative expenses | 565,279 | 150,425 | 126,328 | 141,334 |
| Loss from operations | -565,279 | -150,425* | -126,328 | -141,334 |
| Interest earned on marketable securities held in trust account | 2,718,657 | 2,906,184.5 | 3,232,187 | 3,126,072 |
| Total other income | 2,718,657 | 2,906,184.5* | 3,232,187 | 3,126,072 |
| Net income | 2,153,378 | 2,755,759.5 | 3,105,859 | 2,984,738 |
| Basic EPS | 0.06 | 0.096 | 0.09 | - |
| Diluted EPS | 0.06 | 0.096 | 0.09 | - |
| Basic Average Shares | 28,750,000 | 28,750,000 | 28,750,000 | - |
| Diluted Average Shares | 28,750,000 | 28,750,000 | 28,750,000 | - |
GP-Act III Acquisition Corp. (GPAT)
GP-Act III Acquisition Corp. (GPAT)